Produkty 2331287-27-3

CAS 2331287-27-3 występuje w naszej ofercie pod nazwami: 4-Androsten-11beta-ol-3,17-dione-2,2,4,6,6,16,16-d7, 98 atom % D, min 98% Chemical Purity, 11–Beta–hydroxyandrostenedione–d7, 11-Beta-hydroxyandrostenedione-d7, 99.16%. Oferty producentów: CDN, GLPBio, MedChemExpress. Dostępne opakowania: 0,01g, 0,005g, 1mg, 10 mg, 5 mg, 1 mg.

4-Androsten-11beta-ol-3,17-dione-2,2,4,6,6,16,16-d7, 98 atom % D, min 98% Chemical Purity
CDN
  • opakowanie: 0,01g, 0,005g
  • Warianty: 2
Zobacz produkt
11–Beta–hydroxyandrostenedione–d7
GLPBio
  • opakowanie: 1mg
  • Warianty: 1
od 2141,60
Zobacz produkt
11-Beta-hydroxyandrostenedione-d7, 99.16%
MedChemExpress
  • opakowanie: 10 mg, 5 mg, 1 mg
  • Warianty: 3
od 1801,13
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(8S,9S,10R,11S,13S,14S)-2,2,4,6,6,16,16-heptadeuterio-11-hydroxy-10,13-dimethyl-1,7,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthrene-3,17-dione (CAS 2331287-27-3) to związek chemiczny o wzorze sumarycznym C19H26O3 i masie molowej 309.4 g/mol. Nazwa systematyczna IUPAC: (8S,9S,10R,11S,13S,14S)-2,2,4,6,6,16,16-heptadeuterio-11-hydroxy-10,13-dimethyl-1,7,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthrene-3,17-dione. InChIKey: WSCUHXPGYUMQEX-QTKHEZQUSA-N.

Dane identyfikacyjne
Wzór sumarycznyC19H26O3
Masa molowa309.4 g/mol
Nazwa IUPAC(8S,9S,10R,11S,13S,14S)-2,2,4,6,6,16,16-heptadeuterio-11-hydroxy-10,13-dimethyl-1,7,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthrene-3,17-dione
InChIKeyWSCUHXPGYUMQEX-QTKHEZQUSA-N
SMILES[2H]C1=C2[C@](CC(C1=O)([2H])[2H])([C@H]3[C@H](C[C@]4([C@H]([C@@H]3CC2([2H])[2H])CC(C4=O)([2H])[2H])C)O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 11-Beta-hydroxyandrostenedione-d7, 4-Androsten-11beta-ol-3,17-dione-2,2,4,6,6,16,16-d7, orb2300163, 4-Androsten-11|A-Ol-3,17-Dione-2,2,4,6,6,16,16-D7, 11beta-Hydroxy-4-androstene-3,17-dione-d7 Solution in DMSO, 100ug/mL
Powiązane formy tego związku
(8S,9S,10R,11R,13S,14S)-11-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione C19H26O3
(8S,9S,10R,11S,13S,14S)-11-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione C19H26O3
(9S,10R,11S,13S)-9,11,12,12-tetradeuterio-11-hydroxy-10,13-dimethyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione C19H26O3
Izomery (ten sam wzór sumaryczny)
(2-methyl-4-oxo-3-prop-2-enylcyclopent-2-en-1-yl) 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate C19H26O3
(3E)-3-[(3,5-ditert-butyl-4-hydroxyphenyl)methylidene]oxolan-2-one C19H26O3
cis-[(1S)-2-methyl-4-oxo-3-prop-2-enylcyclopent-2-en-1-yl] (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate C19H26O3
(8R,9S,13S,14S,16R,17S)-3-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-16,17-diol C19H26O3
(2-methyl-4-oxo-3-prop-2-enylcyclopent-2-en-1-yl) 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate C19H26O3
(8S,9R,10S,13S,14S)-9-hydroxy-10,13-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,17-dione C19H26O3
(5S,8R,9S,10S,13S,14S)-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15-dodecahydrocyclopenta[a]phenanthrene-3,16,17-trione C19H26O3
(8S,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-2,6,7,8,9,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-3,11-dione C19H26O3
(8R,9S,10S,13S,14S)-10-(hydroxymethyl)-13-methyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione C19H26O3